Novel rhodanine-thiazole hybrids as potential antidiabetic agents: A structure-based drug design approach DOI
Shankar Gharge, Shankar G. Alegaon, Shriram D. Ranade

и другие.

RSC Medicinal Chemistry, Год журнала: 2024, Номер unknown

Опубликована: Ноя. 21, 2024

New rhodanine–thiazole clubbed compounds (7a–7l) were synthesised and characterised with various spectroscopy methods.

Язык: Английский

Design, synthesis, in-vitro and in-silico studies of 6-bromochromone based thiosemicarbazones as α-glucosidase inhibitors DOI

Kholood A. Dahlous,

Muhammad Ajmal,

Naeem Ullah

и другие.

Journal of Molecular Structure, Год журнала: 2025, Номер unknown, С. 141374 - 141374

Опубликована: Янв. 1, 2025

Язык: Английский

Процитировано

2

Expression of PPAR-γ TF by newly synthesized thiazolidine-2,4-diones to manage glycemic control: Insights from in silico, in vitro and experimental pharmacology in wistar rats DOI
Shankar Gharge, Shankar G. Alegaon, Shriram D. Ranade

и другие.

Bioorganic Chemistry, Год журнала: 2024, Номер 153, С. 107966 - 107966

Опубликована: Ноя. 17, 2024

Язык: Английский

Процитировано

5

Structure-Based Insights into Fatty Acid Modulation of Lipid-Sensing Nuclear Receptors PPARδ/γ for Glycemic Regulation DOI Creative Commons
Shankar Gharge,

Charushila V. Balikai,

Sachin Gudasi

и другие.

Aspects of Molecular Medicine, Год журнала: 2025, Номер unknown, С. 100079 - 100079

Опубликована: Март 1, 2025

Язык: Английский

Процитировано

0

Thiazolidine Based Quinazoline Hybrids: Synthesis, Docking, DFT, Molecular Dynamic Study, and In Vitro Antidiabetic Evaluation DOI
Shankar Gharge, Shankar G. Alegaon, Shriram D. Ranade

и другие.

Russian Journal of Bioorganic Chemistry, Год журнала: 2025, Номер 51(1), С. 177 - 201

Опубликована: Фев. 1, 2025

Язык: Английский

Процитировано

0

Novel quinoline–imidazole derivatives as inhibitors of Mycobacterium tuberculosis : an integrated approach combining molecular dynamics and in-vitro studies DOI

Neha Khebude,

Shankar G. Alegaon, Shriram D. Ranade

и другие.

Molecular Simulation, Год журнала: 2025, Номер unknown, С. 1 - 19

Опубликована: Март 14, 2025

The rationale for designing and synthesising quinoline–imidazole hybrids as antitubercular cytotoxic agents stems from the strategic combination of two bioactive structural motifs to create compounds with enhanced efficacy, dual targeting, potential overcome drug resistance challenges in tuberculosis treatment. Herein, we report design synthesis hybrids. FTIR, Mass, 1H-NMR 13C-NMR spectral data characterised synthesised compounds. These were evaluated their activity against Mycobacterium (MTB) H37Rv Hep G2, normal mouse fibroblast L929 cell lines. evaluation revealed that compound 6 g exhibited promising activities a MIC value 6.26 µg/ml, while, 6d, h 6i showed moderate MTB inhibition. Additionally, 6d demonstrated cytotoxicity HepG2 lines an IC50 46.74 ± 1.209 μg/ml. Further selected underwent theoretical investigation via molecular docking, stability assessment MD trajectories quantum computations justify experimental results. obtained predicted silico indicate act effective inhibitors.

Язык: Английский

Процитировано

0

Novel rhodanine-thiazole hybrids as potential antidiabetic agents: A structure-based drug design approach DOI
Shankar Gharge, Shankar G. Alegaon, Shriram D. Ranade

и другие.

RSC Medicinal Chemistry, Год журнала: 2024, Номер unknown

Опубликована: Ноя. 21, 2024

New rhodanine–thiazole clubbed compounds (7a–7l) were synthesised and characterised with various spectroscopy methods.

Язык: Английский

Процитировано

1